Developmental Funds
发展基金
基本信息
- 批准号:8932943
- 负责人:
- 金额:$ 45.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AreaBasic Cancer ResearchBudgetsCancer CenterCancer Center Support GrantCancer Research ProjectClinicalClinical DataCollectionDecision MakingDevelopmentDiseaseFacultyFundingGoalsGrowthMalignant NeoplasmsMalignant neoplasm of ovaryMolecularOnline SystemsPatientsPhasePilot ProjectsPlayPrimary NeoplasmProcessPrognostic MarkerPublicationsResearchResearch InfrastructureResource SharingResourcesSamplingSpecimenStrategic PlanningTranslational Researchanticancer researchdrug discoveryflexibilitymelanomamemberpatient orientedprogramstoolvalidation studies
项目摘要
: Developmental Funds have continued to play a key role in the global reorganization of the Cancer Center that was initiated during the last CCSG budget period. Supported by a thorough, transparent and inclusive strategic planning process, the Cancer Center has undergone major changes in its administrative infrastructure, refinement of scientific and educational objectives, expansion of programmatic themes and global realignment of Shared Resources. A pivotal aspect of this reorganization was a focused and thematic faculty recruitment effort that led to the hiring of nine new Cancer Center members at all academic ranks and appointed across the three scientific Programs during the last budget period. Judiciously deployed as part of a flexible, inclusive and goal-oriented decision-making process, CCSG Developmental Funds have been instrumental to enable the long-range directives ofthe 2012 Cancer Center Strategic Plan, contributing to new faculty recruitment, facilitating inter-programmatic and collaborative pilot projects, supporting the launch of a new developmental Translational Research Management core, and expanding the collection of clinically annotated primary tumor samples for molecular validation studies, prognostic biomarker assessment and identification of new cancer targets. In this context, CCSG Developmental Funds have tangibly contributed to the sharp upward trajectory of the Cancer Center of the last budget period, reflected in significantly increased cancer focus, growth in NCI and cancer-related funding, expansion of inter- and intraprogrammatic collaborative publications, and launch of a portfolio of scientific initiatives along the continuum of basic, translational and patient-oriented cancer research. Building on these validated principles, CCSG Developmental Funds will continue to support the upward trajectory of the Cancer Center over the next budget period, supporting new faculty recruitment and expanding the Center-wide tools that have been put in place to enable translational and patient-oriented cancer research across all three scientific Programs.
:发展基金继续在 CCSG 上一个预算期间启动的癌症中心全球重组中发挥关键作用。在彻底、透明和包容性战略规划流程的支持下,癌症中心在行政基础设施、科学和教育目标的细化、计划主题的扩展以及共享资源的全球调整等方面发生了重大变化。这次重组的一个关键方面是重点和主题性的教员招聘工作,导致在上一个预算期间聘用了所有学术级别的九名新癌症中心成员,并在三个科学计划中任命。作为灵活、包容和以目标为导向的决策过程的一部分,CCSG 发展基金得到了明智的部署,为实现 2012 年癌症中心战略计划的长期指示发挥了重要作用,有助于新教师的招聘,促进项目间和协作试点项目,支持启动新的开发转化研究管理核心,并扩大临床注释原发性肿瘤样本的收集,用于分子验证研究、预后生物标志物评估和新癌症靶点的识别。在此背景下,CCSG 发展基金为癌症中心在上一个预算期间的急剧上升轨迹做出了切实贡献,这体现在对癌症的关注显着增加、NCI 和癌症相关资金的增长、计划间和计划内合作出版物的扩大、并沿着基础、转化和以患者为导向的癌症研究的连续性推出一系列科学举措。基于这些经过验证的原则,CCSG 发展基金将继续支持癌症中心在下一个预算期间的上升轨迹,支持新的教职员工招聘并扩展已到位的中心范围内的工具,以实现转化和以患者为导向所有三个科学计划的癌症研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dario C Altieri其他文献
Dario C Altieri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dario C Altieri', 18)}}的其他基金
Augmenting T-cell immunotherapy outcomes in blood and solid tumor microenvironment in ART-suppressed HIV infection (immune/microenvironment)
在 ART 抑制的 HIV 感染中增强血液和实体瘤微环境中的 T 细胞免疫治疗效果(免疫/微环境)
- 批准号:
10620011 - 财政年份:2022
- 资助金额:
$ 45.99万 - 项目类别:
A First-in-Human Phase I Clinical Trial of Mitochondrial-Targeted Hsp90 Inhibitor, Gamitrinib
线粒体靶向 Hsp90 抑制剂 Gamitrinib 的首次人体 I 期临床试验
- 批准号:
10472429 - 财政年份:2021
- 资助金额:
$ 45.99万 - 项目类别:
A First-in-Human Phase I Clinical Trial of Mitochondrial-Targeted Hsp90 Inhibitor, Gamitrinib
线粒体靶向 Hsp90 抑制剂 Gamitrinib 的首次人体 I 期临床试验
- 批准号:
9668658 - 财政年份:2021
- 资助金额:
$ 45.99万 - 项目类别:
相似国自然基金
岭南中药蒲葵抑制细胞自噬协同化疗预防癌症骨转移的药效物质基础及机制研究
- 批准号:81503221
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
新型掺杂型荧光量子点的制备及其用于癌症个体化诊断的基础研究
- 批准号:20875036
- 批准年份:2008
- 资助金额:33.0 万元
- 项目类别:面上项目
重离子束辐射治疗癌症的应用基础研究
- 批准号:10835011
- 批准年份:2008
- 资助金额:240.0 万元
- 项目类别:重点项目
微气泡造影剂对癌症的基因治疗的基础研究
- 批准号:30700777
- 批准年份:2007
- 资助金额:15.0 万元
- 项目类别:青年科学基金项目
先进加速器产生的重离子束辐射治疗癌症的应用基础研究
- 批准号:10675151
- 批准年份:2006
- 资助金额:28.0 万元
- 项目类别:面上项目
相似海外基金
University of Florida Health Cancer Center Support Grant
佛罗里达大学健康癌症中心支持补助金
- 批准号:
10625750 - 财政年份:2023
- 资助金额:
$ 45.99万 - 项目类别: